文献速递临床试验与 GCP

活髓治疗用于恒牙龋源性牙髓损伤的疗效:一项开放标签随机对照非劣效性试验的研究方案

Efficacy of vital pulp therapy for carious pulp injury in permanent teeth: a study protocol for an open-label randomized controlled noninferiority trial.
PubMed 文献 · Trials · 2024-10-21

本研究为开放标签、单中心、随机对照非劣效性试验,计划纳入462例18-50岁深龋露髓且诊断为可逆性或部分不可逆性牙髓炎、无根尖透射影、无牙周炎或系统疾病的成熟恒牙患者,随机1:1分为iRoot BP Plus活髓治疗组与根管治疗组,主要结局为成功持续时间,随访至24个月。

要点

  • 拟纳入462例18-50岁成熟恒牙深龋露髓、可逆性或部分不可逆性牙髓炎患者。
  • 随机1:1分入iRoot BP Plus活髓治疗组与根管治疗组,开放标签、单中心、非劣效性设计。
  • 主要结局为成功持续时间,次要结局包括1年成功率及不良反应。

核心结论

  • 该试验结果将为恒牙龋源性牙髓损伤的治疗选择提供临床参考。

研究设计与样本

  • 开放标签、单中心、随机对照非劣效性试验,计划纳入462例患者,按1:1随机分为活髓治疗组与根管治疗组。

主要发现

  • 研究方案阶段,尚未报告疗效结果。

关键数值与推荐

  • 纳入标准为18-50岁成人、成熟恒牙深龋治疗中露髓、X线无根尖透射影的可逆性或部分不可逆性牙髓炎诊断、无牙周炎或系统疾病。
  • 主要结局为成功持续时间;次要结局包括1年随访成功率和任何不良反应。
  • 采用Kaplan-Meier法和log-rank检验比较两组成功持续时间;分类变量用χ2检验或Fisher精确检验,连续变量用t检验或Mann-Whitney U检验。
  • 基线及治疗后3、6、12、24个月进行临床评估,并可能延长。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vital pulp therapy (VPT) has recently been reported as an effective approach for preventing and treating carious pulp injury in permanent teeth. Compared with root canal treatment (RCT), which involves complete removal of the pulp tissue, VPT effectively maintains pulp vitality and retains the physiological functions of the pulp. In the research pool, large-scale randomized controlled trials evaluating the treatment outcome of VPT using calcium silicate cements and RCT in cariously exposed permanent teeth are lacking. Here, we present a monocentric clinical protocol to compare the effects of VPT using iRoot BP Plus (Innovative Bioceramix, Vancouver, BC, Canada) as a pulp-capping material with RCT. METHODS: The proposed trial is an open-label, single-centre, randomized, controlled, noninferiority trial. In total, 462 patients will be included in this trial according to the following criteria: adult patients (18-50 years old), pulp exposure during the treatment of deep caries in mature permanent teeth, a diagnosis of reversible or partially irreversible pulpitis without apical translucency on X-ray, without periodontitis or systemic disease. Patients with signed informed consent forms will be enrolled and randomly divided into two groups (VPT and RCT) with a balanced treatment allocation (1:1). Clinical evaluations will be conducted at baseline and at 3, 6, 12, and 24 months after treatment, with the potential for extension. The primary outcome measure will be the duration of success. The secondary outcomes will include the success rate at the 1-year follow-up and any adverse reactions. The Kaplan‒Meier method and log-rank test will be used to compare the duration of success of both treatments. For other outcomes, the χ2 test or Fisher's exact test will be used for categorical variables, and the t test or Mann‒Whitney U test will be used for continuous variables to assess the differences between groups. DISCUSSION: The results of this trial will provide a clinical reference for selecting treatments for carious pulp injuries in permanent teeth. TRIAL REGISTRATION: ClinicalTrials.gov ChiCTR2100051369. The study has been registered in the Chinese Clinical Trial Registry (ChiCTR) ( www.chictr.org.cn ). Registered on 21 September 2021.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zeng Q, Chen M, Zheng S, et al. Efficacy of vital pulp therapy for carious pulp injury in permanent teeth: a study protocol for an open-label randomized controlled noninferiority trial. Trials. 2024. PMID: 39434172. doi:10.1186/s13063-024-08559-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。